Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

Ayako Arai, MD PhD, Ichiro Yonese, Chizuko Sakashita, MD PhD, Ken-Ichi Imadome, PhD, Tohru Kobayashi, MD PhD, Akihisa Sawada, MD PhD, Yoshinori Ito, MD PhD, Shouichi Ohga, MD PhD, Hiroshi Kimura, MD, Ph. D., Shigeyoshi Fujiwara, MD, PhD

Blood (2018) 132 (Supplement 1): 1631.

https://doi.org/10.1182/blood-2018-99-117854

Published: 2018

Journal Articles

Tumor Cells from EBV-Positive T- or NK-Cell Neoplasms Induce Differentiation and Activation of Macrophages By Secreting Humoral Factors

Akiho Tsuzura, Mayumi Yoshimori, Kanoko Konno, Ken-Ichi Imadome, PhD, Erika Onozawa, Ryunosuke Ohkawa, PhD, Minoru Tozuka, PhD, Osamu Miura, MD, PhD, Ayako Arai, MD, PhD

Blood (2017) 130 (Supplement 1): 4026.

https://doi.org/10.1182/blood.V130.Suppl_1.4026.4026

Published: 2017

Journal Articles

STAT3 Is Activated By EBV in T or NK Cells Leading to Development of EBV-T/NK-Lymphoproliferative Disorders

Honami Komatsu, Ken-Ichi Imadome, PhD, Haruna Shibayama, Tomotaka Yada, Momoko Yamada, Kouhei Yamamoto, MDPhD, Takatoshi Koyama, MD PhD, Shigeyoshi Fujiwara, MD PhD, Osamu Miura, MD PhD, Ayako Arai, MD PhD

Blood (2014) 124 (21): 3026.

https://doi.org/10.1182/blood.V124.21.3026.3026

Published: 2014

Journal Articles

Epstein–Barr Virus Induces Activation-Induced Cytidine Deaminase Expression in T or NK Cells Leading to Mutagenesis and Development of Lymphoma

Ayako Arai, MD, PhD, Masato Horino, Ken-Ichi Imadome, PhD, Kohsuke Imai, MD, PhD, Honami Komatsu, Ludan Wang, MD, Go Matsuda, Kasumi Hamazaki, Morito Kurata, MD, PhD, Tetsuya Kurosu, MD, PhD, Shigeyoshi Fujiwara, MD, PhD, Osamu Miura, MD, PhD

Blood (2013) 122 (21): 1765.

https://doi.org/10.1182/blood.V122.21.1765.1765

Published: 2013

Journal Articles

L-Asparaginase Monotherapy for T- and NK-Cell Type of Chronic Active Epstein-Barr Virus Infection in Adults: A Pilot Study

Ayako Arai, MD, PhD, Minako Jinta, MD, Ken-Ichi Imadome, PhD, Mayumi Yoshimori, Shigeyoshi Fujiwara, MD, PhD, Osamu Miura, MD, PhD

Blood (2011) 118 (21): 4953.

https://doi.org/10.1182/blood.V118.21.4953.4953

Published: 2011

Journal Articles

NF-κB Is Constitutively Activated in EBV-Infected T or NK Cells and Can Be a Molecular Target for EBV-Positive T/NK-Cell Lymphoproliferative Disease Treatment

Ayako Arai, MD, PhD, Mayumi Takahashi, Ken-Ichi Imadome, PhD, Takatoshi Koyama, MD, PhD, Yasunori Saitoh, MD, PhD, Shoji Yamaoka, MD, PhD, Shigeyoshi Fujiwara, MD, PhD, Osamu Miura, MD, PhD

Blood (2010) 116 (21): 1998.

https://doi.org/10.1182/blood.V116.21.1998.1998

Published: 2010

Journal Articles

CD137 Expression Is Enhanced in EBV-Infected T or NK Cells by Viral Protein LMP1 and Mediates Anti-Apoptotic Intracellular Signaling through NF-ĸB Activation.

Ayako Arai, MD, PhD, Ken-ichi Imadome, PhD, Mayumi Takahashi, Koichi Naka, Tetsuya Fukuda, MD, PhD, Shigeyoshi Fujiwara, MD, PhD, Osamu Miura, MD, PhD

Blood (2009) 114 (22): 1929.

https://doi.org/10.1182/blood.V114.22.1929.1929

Published: 2009

NARROW

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

Tumor Cells from EBV-Positive T- or NK-Cell Neoplasms Induce Differentiation and Activation of Macrophages By Secreting Humoral Factors

STAT3 Is Activated By EBV in T or NK Cells Leading to Development of EBV-T/NK-Lymphoproliferative Disorders

Epstein–Barr Virus Induces Activation-Induced Cytidine Deaminase Expression in T or NK Cells Leading to Mutagenesis and Development of Lymphoma

L-Asparaginase Monotherapy for T- and NK-Cell Type of Chronic Active Epstein-Barr Virus Infection in Adults: A Pilot Study

NF-κB Is Constitutively Activated in EBV-Infected T or NK Cells and Can Be a Molecular Target for EBV-Positive T/NK-Cell Lymphoproliferative Disease Treatment

CD137 Expression Is Enhanced in EBV-Infected T or NK Cells by Viral Protein LMP1 and Mediates Anti-Apoptotic Intracellular Signaling through NF-ĸB Activation.

Email alerts

ASH Publications

American Society of Hematology

A Nationwide Survey on Chronic Active Epstein-Barr Virus Infection in Japan Based on New Diagnostic Criteria: Clinical Features and Treatment Strategies

Tumor Cells from EBV-Positive T- or NK-Cell Neoplasms Induce Differentiation and Activation of Macrophages By Secreting Humoral Factors

STAT3 Is Activated By EBV in T or NK Cells Leading to Development of EBV-T/NK-Lymphoproliferative Disorders

Epstein–Barr Virus Induces Activation-Induced Cytidine Deaminase Expression in T or NK Cells Leading to Mutagenesis and Development of Lymphoma

L-Asparaginase Monotherapy for T- and NK-Cell Type of Chronic Active Epstein-Barr Virus Infection in Adults: A Pilot Study

NF-κB Is Constitutively Activated in EBV-Infected T or NK Cells and Can Be a Molecular Target for EBV-Positive T/NK-Cell Lymphoproliferative Disease Treatment

CD137 Expression Is Enhanced in EBV-Infected T or NK Cells by Viral Protein LMP1 and Mediates Anti-Apoptotic Intracellular Signaling through NF-ĸB Activation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only